Moors & Cabot’s PetMed Express PETS Stock Holding History

Moors & Cabot’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,305	Closed	-$244K	–	557
2018 Q3	$244K	Buy	+7,305	New	+$273K	0.03%	475
2018 Q2	–	Sell	-6,131	Closed	-$256K	–	588
2018 Q1	$256K	Buy	+6,131	New	+$283K	0.03%	476

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return

Moors & Cabot's PETS Position: Q4 2018 in Review

Moors & Cabot sold out of PetMed Express (PETS) in Q4 2018, closing a stake of 7,305 shares — an estimated $244K sold.

Moors & Cabot first reported a position in PETS in Q1 2018 and held it in 2 quarters. The position peaked at $256K in Q1 2018. 200 funds tracked by Wall St. Rank hold PETS as of Q4 2018.

Moors & Cabot reported no remaining PetMed Express position as of Q4 2018 after selling out during the quarter.
Moors & Cabot sold 7,305 PetMed Express shares in Q4 2018, an estimated $244K.
Moors & Cabot first reported a position in PetMed Express in Q1 2018 and held it in 2 quarters.
Moors & Cabot's PetMed Express position peaked at $256K in Q1 2018.
200 funds tracked by Wall St. Rank held PetMed Express as of Q4 2018.

Based on Moors & Cabot's 13F filing for Q4 2018, filed 13 Feb 2019.